InMed Pharmaceuticals Inc (INM)

[Aladdin80]

Yes, that's the only benefit of doubt that I still give them. It's a new frontier that they're exploring, but it's been a rather disappointing few yrs watching them continue to take one step forward and two steps back. That doesn't even account for the pipeline reprioritization events. I am truthfully concerned about the biosynthesis program and that's the only reason I'm even here.

I agree 100% and am also concerned that there's very little that would be received by the market as "pump worthy". EB is what it is and on a longer clinical calendar than I would have liked. It would have to be a pump from the biosynthesis program. A industry leading CDMO partner (unlikely) or the approved patent for the bacterial method and new data supporting this method going into batch scale-up.